CRON Q2 2025 Earnings — Cronos Group Inc. Revenue & Financial Results | Market Cap Arena

CRONCronos Group Inc.

$983M

Q2 2025 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$33M+20.5% YoY

Gross Profit

$15M43.4% margin

Operating Income

-$5M-15.9% margin

Net Income

-$40M-118.7% margin

EPS (Diluted)

$-0.10

QoQ Revenue Growth

+3.7%

Cash Flow

Operating Cash Flow

$3M

Free Cash Flow

-$1M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$1.2B

Total Liabilities

$45M

Stockholders' Equity

$1.1B

Cash & Equivalents

$794M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$33M	$28M	+20.5%
Gross Profit	$15M	$6M	+130.3%
Operating Income	-$5M	-$16M	+65.8%
Net Income	-$40M	-$9M	-353.5%

Revenue Segments

Cannabis Flower

$25M75%

Cannabis Extracts

$8M25%

Product and Service, Other

$70,0000%

Geographic Segments

CANADA

$19M57%

ISRAEL

$9M28%

Other Countries

$5M15%